Bionure's Series A Round

Bionure raised a round of funding on May 17, 2018. Investors include Alta Life Sciences.

Bionure is a biotech company developing first - in - class SGK agonists for the treatment of different neurodegenerative disorders for which no treatment options are nowadays available.…

Articles about Bionure's Series A Round: